Neuroblastoma Therapeutic Market Size
Market Size in USD Bn
CAGR7.1%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 7.1% |
| Market Concentration | High |
| Major Players | United Therapeutics, AUM Biosciences, Cellectar Biosciences, Y-mAbs Therapeutics, Seagen Inc. and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Neuroblastoma Therapeutic Market Analysis
The neuroblastoma therapeutic market is estimated to be valued at USD 2.98 Bn in 2025 and is expected to reach USD 4.82 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.1% from 2025 to 2032. Rising drug approvals and emerging pipeline drugs to treat neuroblastoma are further supporting the market growth. Manufacturers are continuously focusing on developing novel therapeutics with improved efficacy and safety against neuroblastoma.